Telos EPS TLS
Diluted earnings per share by quarter and over the last twelve months, from 2019.
- Last 12 months, to Jun 30, 2026
- −$0.21
- Latest quarter, Q2 FY26
- $0.01
- Fiscal year 2025
- −$0.50
Telos' earnings per share was −$0.21 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was $0.01.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$0.50 | n/a |
| FY2024 | −$0.73 | n/a |
| FY2023 | −$0.50 | n/a |
| FY2022 | −$0.80 | n/a |
| FY2021 | −$0.65 | −3350% |
| FY2020 | $0.02 | n/a |
| FY2019 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.01 | n/a | −$0.21 | |
| Q1 FY26 | $0.03 | n/a | −$0.35 | |
| Q4 FY25 | −$0.22 | n/a | −$0.50 | |
| Q3 FY25 | −$0.03 | n/a | −$0.41 | |
| Q2 FY25 | −$0.13 | n/a | −$0.77 | |
| Q1 FY25 | −$0.12 | n/a | −$0.75 | |
| Q4 FY24 | −$0.13 | n/a | −$0.73 | |
| Q3 FY24 | −$0.39 | n/a | −$0.70 | |
| Q2 FY24 | −$0.11 | n/a | −$0.43 | |
| Q1 FY24 | −$0.10 | n/a | −$0.44 | |
| Q4 FY23 | −$0.10 | n/a | −$0.50 | |
| Q3 FY23 | −$0.12 | n/a | −$0.61 |
Against its peers
Companies in Software - Infrastructure nearest Telos' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| TLSTelos | −$0.21 | |
| MKTWMarketwise | $0.87 | −70% a year |
| IIIVi3 Verticals | $0.32 | +10% a year |
| RBBNRibbon Communications | $0.08 | |
| MKLYMcKinley Acquisition | $0.34 | |
| CCSIConsensus Cloud Solutions | $4.94 | +19% a year |
| GDYNGrid Dynamics | $0.02 | −89% a year |
| OSPNOneSpan | $1.77 | +17% a year |
| EGANEGAIN | $0.32 | −72% a year |
| RPDRapid7 | $0.31 | −30% a year |
| RDVTRed Violet | $1.13 | +88% a year |
| Peer median | $0.33 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Telos
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.